Association between time from diagnosis to initiation of systemic therapy of metastatic renal cell carcinoma with treatment outcome
Introduction: In about 30% of cases, renal cell carcinoma (RCC) is detected initially in the metastatic stage (mRCC). The mainstay of mRCC treatment is anti-angiogenesis targeted therapy and immunotherapy which both have significantly prolonged progression-free survival and overall survival in patie...
Main Authors: | Lisičić Nikola, Kević Angelina, Savić Marko, Nikić Predrag |
---|---|
Format: | Article |
Language: | English |
Published: |
University of Belgrade, Medical Faculty
2023-01-01
|
Series: | Medicinski Podmladak |
Subjects: | |
Online Access: | https://scindeks-clanci.ceon.rs/data/pdf/0369-1527/2023/0369-15272303064L.pdf |
Similar Items
-
Real World Overall Survival of Patients With Metastatic Renal Cell Carcinoma Treated With Only Available Sunitinib and Pazopanib in First-Line Setting
by: Predrag Nikic, et al.
Published: (2022-06-01) -
Clinical Significance and Expression Pattern of RIP5 and VGLL4 in Clear Cell Renal Cell Carcinoma Patients Treated with Sunitinib
by: Tanja Tomić, et al.
Published: (2024-01-01) -
Longer Control of Nivolumab in Metastatic Renal Cell Carcinoma Patients with End-Stage Kidney Disease on Dialysis
by: Ryota Morinaga, et al.
Published: (2019-08-01) -
Exploratory Pilot Study of Circulating Biomarkers in Metastatic Renal Cell Carcinoma
by: Ilaria Grazia Zizzari, et al.
Published: (2020-09-01) -
Multidisciplinary Team (MDT) Discussion Improves Overall Survival Outcomes for Metastatic Renal Cell Carcinoma Patients
by: Zeng Y, et al.
Published: (2023-02-01)